A call for increased inclusivity and global representation in pharmacogenetic testing.
April Kennedy et al. NPJ Genom Med 2024 2 (1) 13 (Posted Feb 23, 2024 3PM)
Recent advances in polygenic scores: translation, equitability, methods and FAIR tools.
Ruidong Xiang et al. Genome Med 2024 2 (1) 33 (Posted Feb 22, 2024 11AM)
Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer.
Qingyang Xiao et al. J Natl Cancer Inst 2024 2 (Posted Feb 22, 2024 9AM)
Cost-Effectiveness of Population-Based Multigene Testing for Breast and Ovarian Cancer Prevention.
Fangjian Guo et al. JAMA Netw Open 2024 2 (2) e2356078 (Posted Feb 15, 2024 9AM)
Sook Pin Goh et al. BMC Cancer 2024 24(1) 316
Improving newborn screening test performance for metachromatic leukodystrophy: Recommendation from a pre-pilot study that identified a late-infantile case for treatment.
Teresa H Y Wu et al. Mol Genet Metab 2024 142(1) 108349
Integration and usability of a digital cancer risk stratification tool to optimize identification of patients at risk for hereditary cancers: A pilot study.
Emily M Webster et al. Gynecol Oncol 2024 1831-6
Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer Centre.
Xin Wang et al. Clin Genitourin Cancer 2024 102052
Research biobank participants attitudes towards genetic exceptionalism and health record confidentiality.
Victoria Dortenzio et al. J Community Genet 2024
The Role of Demographic and Clinical Factors in Germline Mutation Testing for Patients with Primary Hyperparathyroidism.
Patrick T Hangge et al. Ann Surg Oncol 2024
Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care.
Mady Head et al. Womens Health Issues 2024
Additional findings from the 100,000 Genomes Project: a qualitative study of recipient perspectives.
Joshua J Nolan et al. Genet Med 2024 101103
Lipoprotein(a) testing in lipid clinics across the UK: Results of a national survey.
Saleem Ansari et al. J Clin Lipidol 2024
The frequency of colorectal lesions in the first-degree relatives of patients with colorectal lesions among PERSIAN Guilan Cohort Study population (PGCS).
Somaieh Matin et al. BMC Gastroenterol 2024 24(1) 88
Efficacy of Community Health Worker-Delivered Family Health History-Based Breast Cancer Education and Services Among Chinese Americans.
Bertille Assoumou et al. J Cancer Educ 2024
Leading Risk Factors for Congenital Deafness in the Context of Universal Neonatal Screening: Our Observations in a Four-Year Retrospective Study.
Antoine Paul et al. Int J Neonatal Screen 2024 10(1)
Genetic Testing in Hypertrophic Cardiomyopathy.
Catherine G Ireland et al. Am J Cardiol 2024 212SS4-S13
Prediction of non-suicidal self-injury in adolescents at the family level using regression methods and machine learning.
Si Chen Zhou et al. J Affect Disord 2024 35267-75
Correlates of U.S. Adults Aged 50-75 Years Having Had a Colorectal Cancer Screening Test.
Aisha T Langford et al. AJPM Focus 2024 3(2) 100187
LFSPROShiny: An Interactive R/Shiny App for Prediction and Visualization of Cancer Risks in Families With Deleterious Germline TP53 Mutations.
Nam H Nguyen et al. JCO Clin Cancer Inform 2024 8e2300167
Genetic testing for familial hypercholesterolemia.
Yiyi Zhang et al. Curr Opin Lipidol 2024
Comparison of Two Strategies for Hypercholesterolemia Detection through Point-of-Care Testing.
Héctor Eliud Arriaga-Cázares et al. Diagnostics (Basel) 2024 14(2)
Using implementation science to develop a familial hypercholesterolemia screening program in primary care: The CARE-FH study.
Laney K Jones et al. J Clin Lipidol 2024
Recommendations for initial diabetic retinopathy screening of diabetic patients using large language model-based artificial intelligence in real-life case scenarios.
Nikhil Gopalakrishnan et al. Int J Retina Vitreous 2024 10(1) 11
A cost-effectiveness analysis of an integrated clinical-radiogenomic screening program for the identification of BRCA 1/2 carriers (e-PROBE study).
A Di Pilla et al. Sci Rep 2024 14(1) 928
Association of Family History and Polygenic Risk Score With Longitudinal Prognosis in Parkinson Disease.
Mincheol Park et al. Neurol Genet 2024 10(1) e200115
Beyond the kidney biopsy: genomic approach to undetermined kidney diseases.
Thomas Robert et al. Clin Kidney J 2024 17(1) sfad099
Evaluation of mailed results versus telephone disclosure of normal cancer genetic test results in a low-risk underserved population.
Marian J Gilmore et al. Transl Behav Med 2024
Surveillance Compliance and Quality of Life Assessment Among Surgical Patients with Familial Adenomatous Polyposis Syndrome.
Noura Alhassan et al. J Epidemiol Glob Health 2024
Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome.
Pavlina Chrysafi et al. Cancers (Basel) 2023 15(24)
Secondary (additional) findings from the 100,000 Genomes Project: disease manifestation, healthcare outcomes and costs of disclosure.
Joshua Nolan et al. Genet Med 2023 101051
Personalized medicine in a community health system: the NorthShore experience.
Sean P David et al. Front Genet 2023 141308738
Returning Genetic Information About Risk for Alcohol Use Disorder to Adolescents: Findings of a Preliminary Qualitative Study of Precision Prevention.
Elissa R Weitzman et al. AJPM Focus 2023 3(1) 100153
Age Matters: Adenoma Detection Rates in Average-risk Screening Patients Aged 45 to 49 Compared With Those Aged 50 to 54.
Shuji Mitsuhashi et al. J Clin Gastroenterol 2023
Assessment of Sudden Cardiac Death Risk in Pediatric Primary Electrical Disorders: A Comprehensive Overview.
Adelina Pupaza et al. Diagnostics (Basel) 2023 13(23)
Associations between alcohol use disorder polygenic score and remission in participants from high-risk families and Indiana biobank.
Dongbing Lai et al. Alcohol Clin Exp Res (Hoboken) 2023
Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction.
Anja Tüchler et al. Breast 2023 73103615
Family history, socioeconomic factors, comorbidities, health behaviors, and the risk of sudden cardiac arrest.
Eujene Jung et al. Sci Rep 2023 13(1) 21341
Impact of family history of cancer on colorectal cancer screening: a propensity score-matched analysis from the Health Information National Trends Survey (HINTS).
Maxwell Akonde et al. J Egypt Natl Canc Inst 2023 35(1) 38
Precision Recruitment and Engagement of Individuals at Risk for Diabetes and Hypertension in Clinical Trials (PREDHICT): A Randomized Trial for an E-Persuasive Mobile Application to Inform Decision Making about Clinical Trials.
Azizi Seixas et al. Int J Environ Res Public Health 2023 20(23)
Unawareness of breast cancer family history among African women.
Babatunde Adedokun et al. Pan Afr Med J 2023 45188
Affected brother as the highest risk factor of type 1 diabetes development in children and adolescents: One center data before implementing type 1 diabetes national screening.
Anna Wedrychowicz et al. Adv Clin Exp Med 2023
Awareness and Candidacy for Endocrine Prevention and Risk Reducing Mastectomy in Unaffected High-Risk Women Referred for Breast Cancer Risk Assessment.
Basmah Alhassan et al. Ann Surg Oncol 2023
Current controversy in prenatal diagnosis: The use of cfDNA to screen for monogenic conditions in low risk populations is ready for clinical use.
Neeta L Vora et al. Prenat Diagn 2023
More
About Family Health History PHGKB
Family Health History PHGKB is an online, continuously updated, searchable database of information and publications relevant to the role of family health history in healthcare and disease prevention....more
Content Summary
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 27, 2024
- Content source: